|
1
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin. Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar
|
|
2
|
Caponigro F, Longo F, Ionna F and Perri F:
Treatment approaches to nasopharyngeal carcinoma: A review.
Anticancer Drugs. 21:471–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang WY, Lin CL, Lin CY, Jen YM, Lo CH,
Sung FC and Kao CH: Survival outcome of patients with
nasopharyngeal carcinoma: A nationwide analysis of 13 407 patients
in Taiwan. Clin Otolaryngol. 40:327–334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li JX, Huang SM, Jiang XH, Ouyang B, Han
F, Liu S, Wen BX and Lu TX: Local failure patterns for patients
with nasopharyngeal carcinoma after intensity-modulated
radiotherapy. Radiat Oncol. 9:872014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li G, Qiu Y, Su Z, Ren S, Liu C, Tian Y
and Liu Y: Genome-wide analyses of radioresistance-associated miRNA
expression profile in nasopharyngeal carcinoma using next
generation deep sequencing. PLoS One. 8:e844862013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Liu Y, Su Z, Ren S, Zhu G, Tian Y
and Qiu Y: MicroRNA-324-3p regulates nasopharyngeal carcinoma
radioresistance by directly targeting WNT2B. Eur J Cancer.
49:2596–2607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marie-Egyptienne DT, Lohse I and Hill RP:
Cancer stem cells, the epithelial to mesenchymal transition (EMT)
and radioresistance: Potential role of hypoxia. Cancer Lett.
341:63–72. 2013. View Article : Google Scholar
|
|
9
|
Kajiyama H, Shibata K, Terauchi M,
Yamashita M, Ino K, Nawa A and Kikkawa F: Chemoresistance to
paclitaxel induces epithelial-mesenchymal transition and enhances
metastatic potential for epithelial ovarian carcinoma cells. Int J
Oncol. 31:277–283. 2007.PubMed/NCBI
|
|
10
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di C and Zhao Y: Multiple drug resistance
due to resistance to stem cells and stem cell treatment progress in
cancer (review). Exp Ther Med. 9:289–293. 2015.PubMed/NCBI
|
|
12
|
Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S,
Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates
nasopharyngeal carcinoma radioresistance by targeting WNT2B in
vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu C, Liu Y, Tan H, Li G, Su Z, Ren S, Zhu
G, Tian Y, Qiu Y and Zhang X: Metadherin regulates metastasis of
squamous cell carcinoma of the head and neck via AKT signalling
pathway-mediated epithelial-mesenchymal transition. Cancer Lett.
343:258–267. 2014. View Article : Google Scholar
|
|
14
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spillane JB and Henderson MA: Cancer stem
cells: A review. ANZ J Surg. 77:464–468. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li WF, Zhang L, Li HY, Zheng SS and Zhao
L: WISP-1 contributes to fractionated irradiation-induced
radioresistance in esophageal carcinoma cell lines and mice. PLoS
One. 9:e947512014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang
PF, Li C, Peng F, Tang CE, Li JL, et al: Identification of
biomarkers for predicting nasopharyngeal carcinoma response to
radiotherapy by proteomics. Cancer Res. 70:3450–3462. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zheng L, Sun Y, Wang T and Wang
B: Tangeretin enhances radiosensitivity and inhibits the
radiation-induced epithelial-mesenchymal transition of gastric
cancer cells. Oncol Rep. 34:302–310. 2015.PubMed/NCBI
|
|
20
|
Ni J, Cozzi PJ, Hao JL, Beretov J, Chang
L, Duan W, Shigdar S, Delprado WJ, Graham PH, Bucci J, et al: CD44
variant 6 is associated with prostate cancer metastasis and
chemo-/radioresistance. Prostate. 74:602–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Jong MC, Ten Hoeve JJ, Grénman R,
Wessels LF, Kerkhoven R, Te Riele H, van den Brekel MW, Verheij M
and Begg AC: Pretreatment microRNA expression impacting on
epithelial-to-mesenchymal transition predicts intrinsic
radio-sensitivity in head and neck cancer cell lines and patients.
Clin Cancer Res. 21:5630–5638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cojoc M, Peitzsch C, Kurth I, Trautmann F,
Kunz-Schughart LA, Telegeev GD, Stakhovsky EA, Walker JR, Simin K,
Lyle S, et al: Aldehyde dehydrogenase is regulated by β-catenin/TCF
and promotes radioresistance in prostate cancer progenitor cells.
Cancer Res. 75:1482–1494. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan S, Wang Y, Yang Q, Li X, Kong X, Zhang
N, Yuan C, Yang N and Kong B: Low-dose radiation-induced
epithelial-mesenchymal transition through NF-κB in cervical cancer
cells. Int J Oncol. 42:1801–1806. 2013.PubMed/NCBI
|
|
25
|
Bottke D, Koychev D, Busse A, Heufelder K,
Wiegel T, Thiel E, Hinkelbein W and Keilholz U: Fractionated
irradiation can induce functionally relevant multidrug resistance
gene and protein expression in human tumor cell lines. Radiat Res.
170:41–48. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ng IO, Lam KY, Ng M, Kwong DL and Sham JS:
Expression of P-glycoprotein, a multidrug-resistance gene product,
is induced by radiotherapy in patients with oral squamous cell
carcinoma. Cancer. 83:851–857. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartkowiak D, Stempfhuber M, Wiegel T and
Bottke D: Radiation- and chemoinduced multidrug resistance in colon
carcinoma cells. Strahlenther Onkol. 185:815–820. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eichholtz-Wirth H and Hietel B: Cisplatin
resistance in mouse fibrosarcoma cells after low-dose irradiation
in vitro and in vivo. Br J Cancer. 70:579–584. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hill BT, Moran E, Etiévant C, Perrin D,
Masterson A, Larkin A and Whelan RD: Low-dose twice-daily
fractionated X-irradiation of ovarian tumor cells in vitro
generates drug-resistant cells overexpressing two multidrug
resistance-associated proteins, P-glycoprotein and MRP1. Anticancer
Drugs. 11:193–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang P, Liu H, Xia F, Zhang QW, Zhang YY,
Zhao Q, Chao ZH, Jiang ZW and Jiang CC: Epithelial-mesenchymal
transition is necessary for acquired resistance to cisplatin and
increases the metastatic potential of nasopharyngeal carcinoma
cells. Int J Mol Med. 33:151–159. 2014.
|
|
31
|
Zhou Z, Zhang L, Xie B, Wang X, Yang X,
Ding N, Zhang J, Liu Q, Tan G, Feng D, et al: FOXC2 promotes
chemoresistance in nasopharyngeal carcinomas via induction of
epithelial mesenchymal transition. Cancer Lett. 363:137–145. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen YA, Lin CH, Chi WH, Wang CY, Hsieh
YT, Wei YH and Chen YJ: Resveratrol impedes the stemness,
epithelial-mesenchymal transition, and metabolic reprogramming of
cancer stem cells in nasopharyngeal carcinoma through p53
activation. Evid Based Complement Alternat Med. 2013:5903932013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang L, Tang H, Kong Y, Xie X, Chen J,
Song C, Liu X, Ye F, Li N, Wang N, et al: LGR5 promotes breast
cancer progression and maintains stem-like cells through activation
of Wnt/β-catenin signaling. Stem Cells. 33:2913–2924. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Civenni G, Malek A, Albino D,
Garcia-Escudero R, Napoli S, Di Marco S, Pinton S, Sarti M, Carbone
GM and Catapano CV: RNAi-mediated silencing of Myc transcription
inhibits stem-like cell maintenance and tumorigenicity in prostate
cancer. Cancer Res. 73:6816–6827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moumen M, Chiche A, Decraene C, Petit V,
Gandarillas A, Deugnier MA, Glukhova MA and Faraldo MM: Myc is
required for β-catenin-mediated mammary stem cell amplification and
tumorigenesis. Mol Cancer. 12:1322013. View Article : Google Scholar
|
|
36
|
Jachetti E, Mazzoleni S, Grioni M,
Ricupito A, Brambillasca C, Generoso L, Calcinotto A, Freschi M,
Mondino A, Galli R, et al: Prostate cancer stem cells are targets
of both innate and adaptive immunity and elicit tumor-specific
immune responses. OncoImmunology. 2:e245202013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dave B, Mittal V, Tan NM and Chang JC:
Epithelial-mesenchymal transition, cancer stem cells and treatment
resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
